220 related articles for article (PubMed ID: 17169457)
1. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.
Patil SD; Papadmitrakopoulos F; Burgess DJ
J Control Release; 2007 Jan; 117(1):68-79. PubMed ID: 17169457
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control.
Patil SD; Papadimitrakopoulos F; Burgess DJ
Diabetes Technol Ther; 2004 Dec; 6(6):887-97. PubMed ID: 15684644
[TBL] [Abstract][Full Text] [Related]
3. Sequential delivery of dexamethasone and VEGF to control local tissue response for carbon nanotube fluorescence based micro-capillary implantable sensors.
Sung J; Barone PW; Kong H; Strano MS
Biomaterials; 2009 Feb; 30(4):622-31. PubMed ID: 18996588
[TBL] [Abstract][Full Text] [Related]
4. PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation.
Bhardwaj U; Sura R; Papadimitrakopoulos F; Burgess DJ
Int J Pharm; 2010 Jan; 384(1-2):78-86. PubMed ID: 19800956
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
Hickey T; Kreutzer D; Burgess DJ; Moussy F
J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
[TBL] [Abstract][Full Text] [Related]
7. Determination of dual delivery for stem cell differentiation using dexamethasone and TGF-beta3 in/on polymeric microspheres.
Park JS; Na K; Woo DG; Yang HN; Park KH
Biomaterials; 2009 Sep; 30(27):4796-805. PubMed ID: 19539364
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
9. Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants.
Kastellorizios M; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2015 Sep; 214():103-11. PubMed ID: 26216396
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression.
Jayant RD; McShane MJ; Srivastava R
Int J Pharm; 2011 Jan; 403(1-2):268-75. PubMed ID: 21050881
[TBL] [Abstract][Full Text] [Related]
11. Polymeric "smart" coatings to prevent foreign body response to implantable biosensors.
Wang Y; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2013 Aug; 169(3):341-7. PubMed ID: 23298616
[TBL] [Abstract][Full Text] [Related]
12. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
Shin SH; Lee J; Lim KS; Rhim T; Lee SK; Kim YH; Lee KY
J Control Release; 2013 Feb; 166(1):38-45. PubMed ID: 23262200
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ
J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169
[TBL] [Abstract][Full Text] [Related]
14. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.
Peattie RA; Rieke ER; Hewett EM; Fisher RJ; Shu XZ; Prestwich GD
Biomaterials; 2006 Mar; 27(9):1868-75. PubMed ID: 16246413
[TBL] [Abstract][Full Text] [Related]
15. Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices.
Bhardwaj U; Sura R; Papadimitrakopoulos F; Burgess DJ
J Diabetes Sci Technol; 2007 Jan; 1(1):8-17. PubMed ID: 19888374
[TBL] [Abstract][Full Text] [Related]
16. Effectable application of vascular endothelial growth factor to critical sized rat calvaria defects.
Yonamine Y; Matsuyama T; Sonomura T; Takeuchi H; Furuichi Y; Uemura M; Izumi Y; Noguchi K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):225-31. PubMed ID: 20034820
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain.
Kasselman LJ; Kintner J; Sideris A; Pasnikowski E; Krellman JW; Shah S; Rudge JS; Yancopoulos GD; Wiegand SJ; Croll SD
J Vasc Res; 2007; 44(4):283-91. PubMed ID: 17406120
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone.
Barcia E; Herrero-Vanrell R; Díez A; Alvarez-Santiago C; López I; Calonge M
Exp Eye Res; 2009 Aug; 89(2):238-45. PubMed ID: 19341729
[TBL] [Abstract][Full Text] [Related]
19. Drug Distribution in Microspheres Enhances Their Anti-Inflammatory Properties in the Gottingen Minipig.
Kastellorizios M; Tipnis N; Papadimitrakopoulos F; Burgess DJ
Mol Pharm; 2015 Sep; 12(9):3332-8. PubMed ID: 26237140
[TBL] [Abstract][Full Text] [Related]
20. VEGF-induced angiogenesis following localized delivery via injectable, low viscosity poly(trimethylene carbonate).
Amsden BG; Timbart L; Marecak D; Chapanian R; Tse MY; Pang SC
J Control Release; 2010 Jul; 145(2):109-15. PubMed ID: 20381557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
